home / stock / dose:cc / dose:cc news

DOSE:CC News and Press, Rapid Dose Therapeutics Corp. From 02/01/23

Stock Information
Company Name: Rapid Dose Therapeutics Corp.
Stock Symbol: DOSE:CC
Market: CNQC
Website: rapid-dose.com
Menu
DOSE:CC DOSE:CC Quote DOSE:CC Short DOSE:CC News DOSE:CC Articles DOSE:CC Message Board
Get DOSE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DOSE:CC - Rapid Dose Therapeutics Reports Quarterly Financial Results for First Three Quarters of the 2023 Fiscal Year

Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year. Now that the Company has completed the filing of its audited financial statements for the fiscal year ended Feb...
DOSE:CC - Rapid Dose Therapeutics Reports Fiscal Year 2022 Financial Results

On Friday, January 27, 2023, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), filed its financial results for the fiscal year ended February 28, 2022. Now that the Company has completed the filing of its audited financial statements for the fisca...

DOSE:CC - Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada's Trade Commissioner Service

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of five Canadian companies accepted into this year’s Venture Mentoring Servi...

DOSE:CC - Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery platform today announced that they have entered i...
DOSE:CC - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated August 29, 2022, the Company and its aud...

DOSE:CC - Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced that it has closed on $230,000 in a first tranche of its previously announ...

DOSE:CC - Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

Rapid Dose Therapeutics Corp. ( “RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cea...
DOSE:CC - Rapid Dose Therapeutics Announces Issuance of Management Cease Trade Order

Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that, further to its press release dated June 16, 2022 (the “Default Announcement”), at th...

DOSE:CC - Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements

Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that it will not be in a position to file its audited annual financial statements for the fiscal year en...

DOSE:CC - Rapid Dose Therapeutics Corp Announces Proposed Private Placement

Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, today announced that it plans to complete a private placement financing (the “ Financing ”) for ...
Previous 10 Next 10